SCHEMBL223398

SCHEMBL223398

C=Cc1ccc(-c2c(F)cc(-c3ccc(CCC)cc3)cc2F)s1

nearest known ligand 0.34

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ RARB P10826 2/20 0.34
▸ RARA P10276 1/20 0.34
▸ RARG P13631 1/20 0.34
▸ NPC1 O15118 2/20 0.33
▸ MAPT P10636 2/20 0.33
▸ RAB9A P51151 2/20 0.33
▸ THRB P10828 2/20 0.33
▸ GFER P55789 1/20 0.33
▸ MEN1 O00255 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ NPSR1 Q6W5P4 1/20 0.32
▸ TP53 P04637 1/20 0.32
▸ PKM P14618 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ HSD17B10 Q99714 1/20 0.32
▸ MCL1 Q07820 1/20 0.32
▸ PRF1 P14222 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26481797 0.93 RARB (0.41) RARBRARARARGMAPTRAB9A
SCHEMBL26481798 0.91 RARB (0.45) RARBRARARARGMAPTRAB9A
SCHEMBL26481796 0.90 PRF1 (0.33) MAPTPRF1
SCHEMBL10292365 0.86 RARB (0.36) RARBRARARARGNPC1MAPT
SCHEMBL26482657 0.84 TAAR1 (0.39) PRF1
SCHEMBL26558581 0.84 PRF1 (0.33) PRF1
SCHEMBL26481735 0.82 PRF1 (0.34) PRF1
SCHEMBL22872121 0.82 RARB (0.38) RARBRARARARGNPC1MAPT
SCHEMBL225979 0.81 RAB9A (0.38) RARBRARARARGNPC1MAPT
SCHEMBL223390 0.81 RARB (0.37) RARBRARARARGNPC1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230323207-A1 LIQUID-CRYSTALLINE MEDIUM MERCK PATENT GMBH (DE) 2023-10-12 — — US disclosed
CN-107011920-B Liquid-crystalline medium comprising thiophene derivatives 默克专利股份有限公司 2021-06-22 — — CN disclosed
EP-2598604-B1 LIQUID CRYSTAL MEDIUM CONTAINING THIOPHENE DERIVATIVES MERCK PATENT GMBH (DE) 2015-11-25 — — EP disclosed
EP-2598604-B1 LIQUID CRYSTAL MEDIUM CONTAINING THIOPHENE DERIVATIVES MERCK PATENT GMBH (DE) 2015-11-25 — — EP disclosed
US-8906261-B2 Liquid crystal medium containing thiophene derivatives MERCK PATENT GMBH (DE) 2014-12-09 — — US disclosed
US-8906261-B2 Liquid crystal medium containing thiophene derivatives MERCK PATENT GMBH (DE) 2014-12-09 — — US disclosed
US-8906261-B2 Liquid crystal medium containing thiophene derivatives MERCK PATENT GMBH (DE) 2014-12-09 — — US disclosed
US-8486297-B2 Thiophene derivatives, and LC media comprising same MERCK PATENT GMBH (DE) 2013-07-16 — — US disclosed
US-8486297-B2 Thiophene derivatives, and LC media comprising same MERCK PATENT GMBH (DE) 2013-07-16 — — US disclosed
US-8486297-B2 Thiophene derivatives, and LC media comprising same MERCK PATENT GMBH (DE) 2013-07-16 — — US disclosed
EP-2398787-B1 Thiophene derivates and liquid crystal media comprising the same MERCK PATENT GMBH (DE) 2013-01-30 — — EP disclosed
EP-2398787-B1 Thiophene derivates and liquid crystal media comprising the same MERCK PATENT GMBH (DE) 2013-01-30 — — EP disclosed
WO-2012013281-A1 LIQUID CRYSTAL MEDIUM CONTAINING THIOPHENE DERIVATIVES MERCK PATENT GMBH (DE) 2012-02-02 — — WO disclosed
WO-2012013281-A1 LIQUID CRYSTAL MEDIUM CONTAINING THIOPHENE DERIVATIVES MERCK PATENT GMBH (DE) 2012-02-02 — — WO disclosed
US-20120001123-A1 THIOPHENE DERIVATIVES, AND LC MEDIA COMPRISING SAME MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2012-01-05 — — US disclosed
US-20120001123-A1 THIOPHENE DERIVATIVES, AND LC MEDIA COMPRISING SAME MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2012-01-05 — — US disclosed
US-20120001123-A1 THIOPHENE DERIVATIVES, AND LC MEDIA COMPRISING SAME MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2012-01-05 — — US disclosed
EP-2398787-A1 THIOPHENE DERIVATES AND LIQUID CRYSTAL MEDIA COMPRISING THE SAME Merck Patent GmbH (DE) 2011-12-28 — — EP disclosed
WO-2010099853-A1 THIOPHENE DERIVATES AND LIQUID CRYSTAL MEDIA COMPRISING THE SAME MERCK PATENT GMBH (DE) 2010-09-10 — — WO disclosed
WO-2010099853-A1 THIOPHENE DERIVATES AND LIQUID CRYSTAL MEDIA COMPRISING THE SAME MERCK PATENT GMBH (DE) 2010-09-10 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120001123-A1 THIOPHENE DERIVATIVES, AND LC MEDIA COMPRISING SAME TEC, TPMT, TST RARB 3907/4885RARA 3956/4885RARG 4205/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback